NGVT 📈 Ingevity - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45688C1071
NGVT: Activated Carbon, Specialty Chemicals, Engineered Polymers
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina. Web URL: https://www.ingevity.com
Additional Sources for NGVT Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NGVT Stock Overview
Market Cap in USD | 1,710m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 2016-05-02 |
NGVT Stock Ratings
Growth 5y | -61.1% |
Fundamental | -40.2% |
Dividend | - |
Rel. Strength Industry | -1371 |
Analysts | 3.75/5 |
Fair Price Momentum | 36.74 USD |
Fair Price DCF | 19.07 USD |
NGVT Dividends
No Dividends PaidNGVT Growth Ratios
Growth Correlation 3m | 60.9% |
Growth Correlation 12m | -31% |
Growth Correlation 5y | -45% |
CAGR 5y | -13.98% |
CAGR/Mean DD 5y | -0.44 |
Sharpe Ratio 12m | -0.14 |
Alpha | -48.77 |
Beta | 1.36 |
Volatility | 50.22% |
Current Volume | 150.4k |
Average Volume 20d | 241.5k |
What is the price of NGVT stocks?
As of December 30, 2024, the stock is trading at USD 40.60 with a total of 150,391 shares traded.
Over the past week, the price has changed by -1.31%, over one month by -16.41%, over three months by +4.10% and over the past year by -14.02%.
As of December 30, 2024, the stock is trading at USD 40.60 with a total of 150,391 shares traded.
Over the past week, the price has changed by -1.31%, over one month by -16.41%, over three months by +4.10% and over the past year by -14.02%.
Is Ingevity a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Ingevity (NYSE:NGVT) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -40.23 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NGVT as of December 2024 is 36.74. This means that NGVT is currently overvalued and has a potential downside of -9.51%.
Probably not. Based on ValueRay Fundamental Analyses, Ingevity (NYSE:NGVT) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -40.23 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NGVT as of December 2024 is 36.74. This means that NGVT is currently overvalued and has a potential downside of -9.51%.
Is NGVT a buy, sell or hold?
Ingevity has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold NGVT.
Ingevity has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold NGVT.
- Strong Buy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for NGVT stock price target?
According to ValueRays Forecast Model, NGVT Ingevity will be worth about 39.9 in December 2025. The stock is currently trading at 40.60. This means that the stock has a potential downside of -1.82%.
According to ValueRays Forecast Model, NGVT Ingevity will be worth about 39.9 in December 2025. The stock is currently trading at 40.60. This means that the stock has a potential downside of -1.82%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 49.5 | 21.9% |
Analysts Target Price | 64.6 | 59% |
ValueRay Target Price | 39.9 | -1.8% |